EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Probiotic Administration Modulates Gut Microbiota and Suppresses Tumor Growth in Murine Models of Colorectal Cancer

Anna Niechcial, Marlene Schwarzfischer iD, Paulina Wawrzyniak iD, Madita Determann, Doris Pöhlmann, Marcin Wawrzyniak iD, Emilie Gueguen iD, Maria R Walker iD, Yasser Morsy iD, Kirstin Atrott, Marijn Wilmink iD, Luise Linzmeier und 4 weitere

International Journal of Molecular Sciences · 06.05.2025 · 26 (9) · 4404

DOI: 10.3390/ijms26094404 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 06.05.2025. Verfasst von Anna Niechcial und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, University Hospital Zurich, University of Zurich, 8091 Zurich, Switzerland. Hauptthemen laut MEDLINE: Probiotics, Gastrointestinal Microbiome, Colorectal Neoplasms. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: PiLeJe SA, France.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Colorectal cancer (CRC) is a leading cause of cancer-related mortality worldwide with limited treatment options for advanced disease stages. Growing evidence implicates the gut microbiota in CRC pathogenesis, prompting interest in probiotics as a potential therapeutic strategy. In this study, we evaluated the effects of two probiotic compositions, CI (a mix of lactobacilli and bifidobacteria) and CII (bifidobacteria alone), in two murine CRC models: the orthotopic MC-38 cecum injection model and the inflammation-driven azoxymethane/dextran sodium sulfate (AOM/DSS) model. CI showed significant anti-tumor effects in the orthotopic model, reducing tumor weight and volume, which was, however, not associated with robust immune activation, suggesting microbiota-driven mechanisms. In contrast, CII was more effective in the AOM/DSS model, reducing colonic inflammation and completely preventing tumor development. Our study demonstrates that probiotics might have great therapeutic potential via modulation of the gut microbiota, and they can exert anti-tumor effects in murine models of CRC with distinct compositions showing differential efficacy depending on the model. CI stabilized the gut microbiome and inhibited pro-tumorigenic taxa in the MC-38 cecum injection model, while CII exhibited anti-inflammatory properties in the AOM/DSS model, highlighting the potential of probiotics as context-specific interventions for CRC. These findings contribute to the growing body of evidence supporting microbiota-targeted strategies in oncology and their relevance for therapeutic applications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProbioticsGastrointestinal MicrobiomeColorectal NeoplasmsAnimalsMiceDisease Models, AnimalDextran SulfateAzoxymethaneCell Line, TumorBifidobacteriumLactobacillusMaleMice, Inbred C57BL

Stichwörter der Autor:innen

BifidobacteriumLactobacillusanti-tumor activitycolorectal cancerprobiotics

Substanzen

Dextran SulfateAzoxymethane

Autor:innen und Institutionen

  • Department of Gastroenterology and Hepatology, University Hospital Zurich, University of Zurich, 8091 Zurich, Switzerland.
  • PiLeJe Laboratoire, 49270 Paris, France.

ORCID-Profile: Marlene Schwarzfischer, Paulina Wawrzyniak, Marcin Wawrzyniak, Emilie Gueguen, Maria R Walker, Yasser Morsy, Marijn Wilmink, Marianne R Spalinger, Anne Leblanc

Förderung

  • PiLeJe SA, France

Zitieren

APA

Niechcial, A., Schwarzfischer, M., Wawrzyniak, P., Determann, M., Pöhlmann, D., Wawrzyniak, M., Gueguen, E., Walker, M. R., Morsy, Y., Atrott, K., Wilmink, M., Linzmeier, L., Spalinger, M. R., Holowacz, S., Leblanc, A., & Scharl, M. (2025). Probiotic Administration Modulates Gut Microbiota and Suppresses Tumor Growth in Murine Models of Colorectal Cancer. International Journal of Molecular Sciences, 26(9), 4404. https://doi.org/10.3390/ijms26094404

Vancouver

Niechcial A, Schwarzfischer M, Wawrzyniak P, Determann M, Pöhlmann D, Wawrzyniak M, et al. Probiotic Administration Modulates Gut Microbiota and Suppresses Tumor Growth in Murine Models of Colorectal Cancer. International Journal of Molecular Sciences. 2025;26(9):4404. doi:10.3390/ijms26094404

BibTeX
@article{Niechcial2025,
  author = {Niechcial, Anna and Schwarzfischer, Marlene and Wawrzyniak, Paulina and Determann, Madita and Pöhlmann, Doris and Wawrzyniak, Marcin and Gueguen, Emilie and Walker, Maria R and Morsy, Yasser and Atrott, Kirstin and Wilmink, Marijn and Linzmeier, Luise and Spalinger, Marianne R and Holowacz, Sophie and Leblanc, Anne and Scharl, Michael},
  title = {Probiotic Administration Modulates Gut Microbiota and Suppresses Tumor Growth in Murine Models of Colorectal Cancer},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {9},
  pages = {4404},
  doi = {10.3390/ijms26094404}
}
Kostenlos starten →